Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01
Published October 20, 2021 · Recall initiated: September 24, 2021
Summary
FDA records drug Class I recall D-0009-2022, published October 20, 2021 and initiated September 24, 2021. Recalling firm: Eli Lilly & Company; Status: Terminated; Reported quantity: 19,174 syringes; Lot: Lot #: D239382D, Exp. Date April 2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Eli Lilly & Company
- Distributor
- Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico
- Lot
- Lot #: D239382D, Exp. Date April 2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection),April 24, 2024
- FDAPotassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by:October 20, 2021
- FDAGreen Field Farms Chocolate Milk 1/2 gallon glass jar, 6 units per case 53oz plastic bottle, 6 units per caseOctober 20, 2021
- FDAFAIRLIFE MILK 8OZ / 6PK CHOCOLATE (multi-pack format of small single serve bottle); Date Code "MAY2722 FA";October 20, 2021
- FDAZoll, REF 8700-0657-40 (IC-3893AE), ICY Intravascular Heat Intravascular Heat Exchange Catheter Kit, withOctober 13, 2021
- FDAZyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA,August 18, 2021
Questions about this recall
Was Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01 recalled?
Yes. FDA published recall D-0009-2022 on October 20, 2021. Reported hazard: SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release